This article describes research conducted on a range of antimalarial drugs, procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries which were subjected to semi-quantitative thin-layer chromatography (TLC) and dissolution testing to measure active pharmaceutical ingredient content against internationally acceptable standards
This report assesses the quality of antiretroviral medicines obtained at accredited public and private sector antiretroviral procurement and treatment sites in selected African countries. The aim is to help with the development of appropriate quality assurance strategies for antiretrovirals
This case-based brief illustrates how one hospital was able to introduce policy and system changes to reduce corruption and increase responsible stewardship of user fee revenues for the public good.
This document brings together the outcomes of six surveys into medicine prices - for Ghana, Kenya, Mali, Tanzania, Chad and Uganda - and one for the East African Community (Kenya, Uganda and Tanzania) . The reports for Mali and Chad are written in French and the others in English
This paper reviews a model of health care delivery for the poorest, developed in Kenya. "It illustrates that a pro-poor health system can be developed if the true representatives of the poorest are enabled to participate in health care delivery, and good governance and proper systems are established...With the active involvement of the community in a mutually supportive manner, the utilisation of services and access to basic health care for the poorest can be improved"
This paper examines Kenyan legislation and policy in light of the international intellectual property rights framework, in particular the World Trade Oorganization’s Doha Ministerial Declaration decision. It considers the existing sources of supply and associated trends in pricing of pharmaceutical products in Kenya, placing the focus on medicines that are, or are likely to be, affected by these rights
Documents MSF's experience of purchasing anti-retroviral drugs in ten low and middle income countries. The report looks at ARV selection, pricing and procurement issues. It highlights five issues: sources (quality), registration, prices, patents, and the continous availability of medicines
This paper presents an overview of the development of drug regulation and the rationale for drug regulation. It also reviews the drug regulation situation in selected countries, examines key contributing factors to observed drug regulation weaknesses, and identifies the measures that must be taken to improve drug regulation
Source e-bulletin on Disability and Inclusion